All GLP-1 Journey Guides
235 hand-edited guides organized by topic, category, and medication. New guides go live every day.
warningSerious & rare · 11 guides
Gallbladder, hypoglycemia, plus reported anecdotal effects (vision, tinnitus, hot flashes, etc.).
GLP-1 and Libido: How Sex Drive Can Change
Some GLP-1 users feel their libido rise; others feel it drop. Neither is on the label. Here is what is likely happening and what to do about it.
Read guidearrow_forwardPeriod Changes on GLP-1: Why Your Cycle Might Shift
GLP-1s do not act directly on menstrual hormones, but rapid weight loss reshapes them. Cycles often regularize in PCOS — and can pause altogether with aggressive loss.
Read guidearrow_forwardWhy You Feel Cold on GLP-1 Medications
Feeling cold on a GLP-1 is not on the label, but it is one of the most consistent off-label reports. Here is the likely mechanism and when to investigate.
Read guidearrow_forwardHot Flashes on GLP-1: Is It the Drug or Something Else?
Hot flashes on GLP-1s are not on the label, but they are reported — sometimes from the drug, sometimes from rapid weight loss, sometimes from menopause hiding underneath.
Read guidearrow_forwardGLP-1 and Ringing in the Ears: What Users Report
Tinnitus is not on any GLP-1 label, but reports exist. Most are likely incidental — but the patterns worth investigating are specific and not all benign.
Read guidearrow_forwardGLP-1 Vision Changes: When Blurry Vision Means Something
Most blurry vision on GLP-1s is transient and benign — but a rare optic nerve signal and diabetic retinopathy risk deserve real attention. Here is what to know.
Read guidearrow_forwardVivid Dreams on GLP-1: What's Causing Them
Many GLP-1 users report dreams that are sharper, weirder, or more emotional. It is anecdotal, not labeled — but there are real mechanisms worth understanding.
Read guidearrow_forwardSemaglutide and Gallbladder Issues: What the Data Says
Gallbladder problems affected ~2.6% of Wegovy users in trials versus 1.2% on placebo. Here's the evidence, the warning signs, and how to lower your risk.
Read guidearrow_forwardSemaglutide and Low Blood Sugar: When Hypoglycemia Actually Happens
Hypoglycemia is rare on semaglutide alone but a real risk if you combine it with insulin or sulfonylureas. Here's who's at risk and the warning signs.
Read guidearrow_forwardTirzepatide Gallbladder Issues: What the SURMOUNT Data Shows
Gallbladder events occurred in roughly 0.5–2.5% of Zepbound users in SURMOUNT-1 vs. 0.6% on placebo. Here's the mechanism, risk factors, and red flags.
Read guidearrow_forwardTirzepatide and Low Blood Sugar: Risk Profile and Prevention
Tirzepatide alone causes hypoglycemia in about 4% of non-diabetic users. Combined with insulin or sulfonylureas, the risk multiplies. Here's how to manage it.
Read guidearrow_forward